RelB upregulates PD-L1 and exacerbates prostate cancer immune evasion

Overview of attention for article published in Journal of Experimental & Clinical Cancer Research, February 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (51st percentile)
Average Attention Score compared to outputs of the same age and source

So far, Altmetric has seen 3 tweets from 3 users, with an upper bound of 4,371 followers.

Nanjing Medical University scientists show that RelB participates in the immune evasion of #ProstateCancer via cis/trans transcriptional upregulation of PD-L1. #OpenAccess here: 💡 https://t.co/jKU1y2R06e https://t.co/akKszReQIH

RelB upregulates PD-L1 and exacerbates prostate cancer immune evasion. https://t.co/Uk5YS0YuzC

New article: RelB upregulates PD-L1 and exacerbates prostate cancer immune evasion https://t.co/YSGYa8ukg3 #prostatecancer #oncology https://t.co/S7wih3S7WT

This page shows the most recent tweets that mention this research output.

Click here to find out how to access more activity.